Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals
Financial Summary Report of Fresenius Kabi Oncology Ltd.
FKONCO
Fresenius Kabi Oncology Ltd.
Rs. 132.50
02-Jan-2014
5 Yr Performance
1 Yr Performance
Valuation
Quarterly
Earnings Yield
Analysis
Quarterly Revenue, Net Income and Adjusted Share Price
Peer Comparison
Glaxosmithkline Pharmaceuticals Ltd.